1-160881156-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_017625.3(ITLN1):āc.562C>Gā(p.Gln188Glu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000311 in 1,607,314 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_017625.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITLN1 | ENST00000326245.4 | c.562C>G | p.Gln188Glu | missense_variant, splice_region_variant | 5/8 | 1 | NM_017625.3 | ENSP00000323587.3 | ||
ITLN1 | ENST00000464077.1 | n.496C>G | splice_region_variant, non_coding_transcript_exon_variant | 2/2 | 2 | |||||
ITLN1 | ENST00000487531.1 | n.366C>G | splice_region_variant, non_coding_transcript_exon_variant | 1/3 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152198Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000163 AC: 4AN: 244882Hom.: 0 AF XY: 0.00000757 AC XY: 1AN XY: 132174
GnomAD4 exome AF: 0.00000275 AC: 4AN: 1455116Hom.: 0 Cov.: 33 AF XY: 0.00000138 AC XY: 1AN XY: 723446
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152198Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74354
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 13, 2022 | The c.562C>G (p.Q188E) alteration is located in exon 5 (coding exon 4) of the ITLN1 gene. This alteration results from a C to G substitution at nucleotide position 562, causing the glutamine (Q) at amino acid position 188 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at